XXII logo

22nd Century Group, Inc. (XXII)

Profile

Full Name

22nd Century Group, Inc.

Ticker

NASDAQ: XXII

Exchange

NASDAQ

Sector

Consumer Defensive

Industry

Tobacco

Country

United States

IPO

January 26, 2011

Indexes

Not included

Website

http://www.xxiicentury.com

Employees

56

Key Details

Price

$6.18(-9.12%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.88M(-26.66% YoY)

Annual EPS

-$4047.77(+97.65% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.18
    XXII price is $6.18

    30-Day Relative Volume

    15.14
    XXII 30-day relative volume is 15.14

    Price Performance

    Price Most recent change

    -9.12%
    XXII price was down -9.12% on Jul 11, 2025

    Price YTD change

    -94.94%
    XXII price is down -94.94% since January 1st

    Price 1-year change

    -99.75%
    XXII price is down -99.75% year-on-year

    Price 3-year change

    -100%
    XXII price is down -100% over the past 3 years

    Price Range

    Price All-time high

    $4739472.00
    XXII price is currently -100.00% below its historical high of $4739472.00

    Price 3-year low

    $5.73
    XXII price is currently +7.83% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.12M
    XXII market capitalization is $2.12 million

    Market cap 3-year change

    -99.54%
    XXII market capitalization is down -99.54% over the past 3 years

    Market cap All-time high

    $837.60M
    XXII market capitalization is currently -99.75% below its historical high of $837.60 million

    Market cap sector rank

    4.3%
    XXII market capitalization is higher than 4.3% of companies in Consumer Defensive sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +11360%
    XXII shares outstanding is up +11360% year-on-year

    Shares Outstanding 3-Year Change

    +114500%
    XXII shares outstanding is up +114500% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.99
    XXII beta is 0.99

    200-day SMA

    $153.88
    XXII price is currently -95.98% below its 200-day simple moving average

    50-day SMA

    $16.54
    XXII price is currently -62.63% below its 50-day simple moving average

    RSI

    24.49
    XXII 14-day relative strength index is 24.49

    Volume

    15.14
    XXII 30-day relative volume is 15.14

    ATR

    $1.07
    XXII average true range is $1.07

    10-day Historical Volatility

    96.35%
    XXII 10-day historical volatility is 96.35%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $11.88M
    XXII annual revenue is $11.88 million

    Revenue Analysts estimate

    $34.53M
    XXII annual revenue is currently -65.60% lower than the consensus analysts' forecast

    Revenue 1-year change

    -26.66%
    XXII annual revenue is down -26.66% year-on-year

    Revenue Sector rank

    14.73%
    XXII annual revenue is higher than 14.73% of companies in Consumer Defensive sector

    EPS

    EPS

    -$4047.77
    XXII annual earnings per share is -$4047.77

    EPS Analysts estimate

    -
    XXII annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +97.65%
    XXII annual earnings per share is up +97.65% year-on-year

    EPS Sector rank

    0.78%
    XXII annual earnings per share is higher than 0.78% of companies in Consumer Defensive sector

    Profit

    Gross profit

    -$2.40M
    XXII annual gross profit is -$2.40 million

    Gross margin

    -20.21%
    XXII annual gross profit margin is -20.21%

    Operating profit

    -$13.82M
    XXII annual operating income is -$13.82 million

    Operating margin

    -116.35%
    XXII annual operating profit margin is -116.35%

    Net income

    -$15.16M
    XXII annual net profit is -$15.16 million

    Net margin

    -127.66%
    XXII annual net profit margin is -127.66%

    Expenses

    Total expenses

    $25.70M
    XXII annual total expenses is $25.70 million

    Operating expenses

    $11.42M
    XXII annual total operating expenses is $11.42 million

    Cost of goods sold

    $14.28M
    XXII annual cost of goods sold is $14.28 million

    Selling, general & administrative expenses

    $10.29M
    XXII annual SGA is $10.29 million

    Depreciation and amortization

    $1.26M
    XXII annual depreciation & amortization is $1.26 million

    Interest expense

    $2.09M
    XXII annual interest expense is $2.09 million

    Income tax

    $30.00K
    XXII annual income tax is $30.00 thousand

    EBIT & EBITDA

    EBIT

    -$13.37M
    XXII annual earnings before interest & taxes is -$13.37 million

    EBITDA

    -$12.11M
    XXII annual EBITDA is -$12.11 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $21.67M
    XXII annual total assets is $21.67 million

    Non current assets

    $10.15M
    XXII annual long term assets is $10.15 million

    Current assets

    $11.52M
    XXII annual total current assets is $11.52 million

    Cash and cash equivalents

    $4.42M
    XXII annual cash & cash equivalents is $4.42 million

    Accounts receivable

    $1.70M
    XXII annual accounts receivable is $1.70 million

    Inventory

    $2.02M
    XXII annual inventory is $2.02 million

    Liabilities

    Total liabilities

    $17.66M
    XXII annual total liabilities is $17.66 million

    Long term liabilities

    $7.70M
    XXII annual total long term liabilities is $7.70 million

    Current liabilities

    $9.96M
    XXII annual total current liabilities is $9.96 million

    Accounts payable

    $2.40M
    XXII annual accounts payable is $2.40 million

    Debt

    Total debt

    $8.62M
    XXII annual total debt is $8.62 million

    Total debt 1-year change

    -47.39%
    XXII annual total debt is down -47.39% year-on-year

    Long term debt

    $6.60M
    XXII annual long term debt is $6.60 million

    Short term debt

    $2.02M
    XXII annual short term debt is $2.02 million

    Equity & Capital

    Shareholders equity

    $4.01M
    XXII annual stockholders equity is $4.01 million

    Book value

    $4.01M
    XXII annual book value is $4.01 million

    Retained earnings

    -$393.87M
    XXII annual retained earnings is -$393.87 million

    Working capital

    $1.56M
    XXII annual working capital is $1.56 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$14.35M
    XXII annual cash flow from operations is -$14.35 million

    Cash from operations 1-year change

    +73.91%
    XXII annual cash flow from operations is up +73.91% year-on-year

    Cash from investing

    -$139.00K
    XXII annual cash flow from investing activities is -$139.00 thousand

    Cash from investing 1-year change

    -100.83%
    XXII annual cash flow from investing activities is down -100.83% year-on-year

    Cash from financing

    $16.85M
    XXII annual cash flow from financing activities is $16.85 million

    Cash from financing 1-year change

    -54.72%
    XXII annual cash flow from financing activities is down -54.72% year-on-year

    CAPEX

    CAPEX

    $161.00K
    XXII annual capital expenditures is $161.00 thousand

    CAPEX 1-year change

    -97.13%
    XXII annual capital expenditures is down -97.13% year-on-year

    Free Cash Flow

    Free cash flow

    -$14.51M
    XXII annual free cash flow is -$14.51 million

    Free cash flow 1-year change

    +76.06%
    XXII annual free cash flow is up +76.06% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -20.21%
    XXII annual gross profit margin is -20.21%

    Operating margin

    -116.35%
    XXII annual operating profit margin is -116.35%

    Net margin

    -127.66%
    XXII annual net profit margin is -127.66%

    ROA & ROE

    ROA

    -61.67%
    XXII annual return on assets is -61.67%

    ROE

    -377.97%
    XXII annual return on equity is -377.97%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    XXII price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    XXII price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.59
    XXII price to book ratio is 0.59

    PB ratio Sector rank

    24.8%
    XXII price to book ratio is higher than 24.8% of companies in Consumer Defensive sector

    PS Ratio

    PS ratio

    0.19
    XXII price to sales ratio is 0.19

    PS ratio Sector rank

    10.05%
    XXII price to sales ratio is higher than 10.05% of companies in Consumer Defensive sector

    Enterprise value

    Enterprise value

    $6.56M
    XXII enterprise value is $6.56 million

    Enterprise value Sector rank

    7.11%
    XXII enterprise value is higher than 7.11% of companies in Consumer Defensive sector

    EV/EBITDA

    EV/EBITDA

    -0.63
    XXII EV/EBITDA is -0.63

    EV/EBITDA Sector rank

    22.94%
    XXII EV/EBITDA is higher than 22.94% of companies in Consumer Defensive sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.16
    XXII annual current ratio is 1.16

    Quick ratio

    0.95
    XXII annual quick ratio is 0.95

    Leverage

    Debt to equity

    1.72
    XXII annual debt to equity ratio is 1.72

    Interest coverage ratio

    -6.39
    XXII annual interest coverage ratio is -6.39

    Risk & Stability

    Piotroski F-Score

    4
    XXII piotroski f-score is 4

    Altman Z-Score

    -26.77
    XXII altman z-score is -26.77

    Analyst ratings

    Recent major analysts updates

    Aug 23, 23 Roth MKM
    Buy
    Aug 17, 23 Alliance Global Partners
    Neutral
    Aug 15, 23 TD Cowen
    Market Perform
    Aug 15, 23 Dawson James
    Buy
    Jul 3, 23 Dawson James
    Buy
    Nov 9, 22 Alliance Global Partners
    Buy
    Jul 21, 22 Alliance Global Partners
    Buy
    Jun 15, 22 Craig-Hallum
    Buy
    Mar 8, 22 Roth Capital
    Buy
    Mar 4, 22 Dawson James
    Buy

    Institutional Ownership

    Screeners with XXII included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    All stocks
    NASDAQ Listed Companies
    Consumer defensive sector
    Ex Dividend dates calendar
    Stocks with low RSI
    • What is the ticker symbol for 22nd Century Group, Inc.?
    • Does 22nd Century Group, Inc. pay dividends?
    • What sector is 22nd Century Group, Inc. in?
    • What industry is 22nd Century Group, Inc. in?
    • What country is 22nd Century Group, Inc. based in?
    • When did 22nd Century Group, Inc. go public?
    • Is 22nd Century Group, Inc. in the S&P 500?
    • Is 22nd Century Group, Inc. in the NASDAQ 100?
    • Is 22nd Century Group, Inc. in the Dow Jones?
    • When was 22nd Century Group, Inc.'s last earnings report?
    • When does 22nd Century Group, Inc. report earnings?

    What is the ticker symbol for 22nd Century Group, Inc.?

    The ticker symbol for 22nd Century Group, Inc. is NASDAQ:XXII

    Does 22nd Century Group, Inc. pay dividends?

    No, 22nd Century Group, Inc. does not pay dividends

    What sector is 22nd Century Group, Inc. in?

    22nd Century Group, Inc. is in the Consumer Defensive sector

    What industry is 22nd Century Group, Inc. in?

    22nd Century Group, Inc. is in the Tobacco industry

    What country is 22nd Century Group, Inc. based in?

    22nd Century Group, Inc. is headquartered in United States

    When did 22nd Century Group, Inc. go public?

    22nd Century Group, Inc.'s initial public offering (IPO) was on January 26, 2011

    Is 22nd Century Group, Inc. in the S&P 500?

    No, 22nd Century Group, Inc. is not included in the S&P 500 index

    Is 22nd Century Group, Inc. in the NASDAQ 100?

    No, 22nd Century Group, Inc. is not included in the NASDAQ 100 index

    Is 22nd Century Group, Inc. in the Dow Jones?

    No, 22nd Century Group, Inc. is not included in the Dow Jones index

    When was 22nd Century Group, Inc.'s last earnings report?

    22nd Century Group, Inc.'s most recent earnings report was on May 13, 2025

    When does 22nd Century Group, Inc. report earnings?

    The next expected earnings date for 22nd Century Group, Inc. is August 13, 2025
    On this page